Clovis Oncology IncのEBIT margin
Clovis Oncology IncのEBIT marginは何ですか。
Clovis Oncology IncのEBIT marginは-161.75%です。
EBIT marginの定義は何ですか。
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
NASDAQのセクタHealth CareにおけるEBIT marginの企業と比べるClovis Oncology Inc
Clovis Oncology Incと類似のebit margin
- W Resources PlcのEBIT marginは-164.36%です。
- Haydale Graphene Industries plcのEBIT marginは-163.70%です。
- Nektar TherapeuticsのEBIT marginは-163.64%です。
- NicholasのEBIT marginは-162.88%です。
- SenSen NetworksのEBIT marginは-162.60%です。
- Kiadis Pharma N.VのEBIT marginは-161.82%です。
- Clovis Oncology IncのEBIT marginは-161.75%です。
- co.don AGのEBIT marginは-161.62%です。
- Noida Toll BridgeのEBIT marginは-161.17%です。
- Xcel Brands IncのEBIT marginは-160.69%です。
- Durect CorpのEBIT marginは-160.60%です。
- Petros PharmaceuticalsのEBIT marginは-159.30%です。
- Xelpmoc Design and TechのEBIT marginは-159.13%です。